Max Robotics — Global Service Robot Directory + US Certification

About

Luca Visani is a leading clinical researcher in radiation oncology, with a primary focus on breast cancer treatment innovation. His major contributions center on the development and validation of preoperative partial breast irradiation (PBI) using robotic radiosurgery, a technique designed to treat well-defined tumor targets with high precision. His most cited work, the phase II ROCK trial (NCT03520894), enrolled early breast cancer patients and demonstrated the feasibility and safety of this approach, earning 29 citations and establishing a new paradigm for non-invasive breast cancer management. Visani’s research bridges the gap between advanced radiotherapy technology and patient-centered outcomes, aiming to reduce treatment toxicity while maintaining oncological efficacy. His work has significant implications for de-escalating breast cancer therapy, potentially shortening treatment courses and improving quality of life. As a clinician-scientist, Visani continues to shape the future of stereotactic body radiotherapy in oncology, with his trial results informing ongoing clinical practice and inspiring further investigation into preoperative radiosurgery for other solid tumors.